Jazz Pharmaceuticals Net Income 2007-2019 | JAZZ

Jazz Pharmaceuticals annual/quarterly net income history and growth rate from 2007 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Jazz Pharmaceuticals net income for the quarter ending September 30, 2019 was $0.102B, a 31.5% decline year-over-year.
  • Jazz Pharmaceuticals net income for the twelve months ending September 30, 2019 was $0.609B, a 17.12% increase year-over-year.
  • Jazz Pharmaceuticals annual net income for 2018 was $0.447B, a 8.35% decline from 2017.
  • Jazz Pharmaceuticals annual net income for 2017 was $0.488B, a 22.94% increase from 2016.
  • Jazz Pharmaceuticals annual net income for 2016 was $0.397B, a 20.42% increase from 2015.
Jazz Pharmaceuticals Annual Net Income
(Millions of US $)
2018 $447
2017 $488
2016 $397
2015 $330
2014 $58
2013 $216
2012 $289
2011 $125
2010 $33
2009 $-7
2008 $-184
2007 $-139
2006 $-81
2005 $-85
Jazz Pharmaceuticals Quarterly Net Income
(Millions of US $)
Q3 2019 $102
Q2 2019 $262
Q1 2019 $85
Q4 2018 $159
Q3 2018 $149
Q2 2018 $92
Q1 2018 $46
Q4 2017 $232
Q3 2017 $64
Q2 2017 $106
Q1 2017 $87
Q4 2016 $117
Q3 2016 $90
Q2 2016 $115
Q1 2016 $76
Q4 2015 $83
Q3 2015 $88
Q2 2015 $88
Q1 2015 $71
Q4 2014 $82
Q3 2014 $26
Q2 2014 $44
Q1 2014 $-93
Q4 2013 $55
Q3 2013 $75
Q2 2013 $42
Q1 2013 $43
Q4 2012 $201
Q3 2012 $33
Q2 2012 $27
Q1 2012 $28
Q4 2011 $37
Q3 2011 $32
Q2 2011 $33
Q1 2011 $22
Q4 2010 $24
Q3 2010 $13
Q2 2010 $-6
Q1 2010 $1
Q4 2009 $6
Q3 2009 $-2
Q2 2009 $2
Q1 2009 $-13
Q4 2008 $-57
Q3 2008 $-29
Q2 2008 $-52
Q1 2008 $-47
Q4 2007 $-60
Q3 2007 $-19
Q2 2007 $-40
Q1 2007 $-20
Q4 2006
Q3 2006 $8
Q2 2006 $-24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.666B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.177B 39.44
Takeda Pharmaceutical (TAK) Japan $57.885B 10.26
Astellas Pharma (ALPMY) Japan $32.280B 16.12
Eisai (ESALY) Japan $22.973B 44.29
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $17.471B 22.89
Merck (MKGAF) Germany $17.318B 23.63
Neurocrine Biosciences (NBIX) United States $9.520B 264.49
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.621B 17.46
Catalent (CTLT) United States $8.609B 35.42
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $6.033B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.175B 15.74
United Therapeutics (UTHR) United States $4.714B 0.00
Evotec AG (EVTCY) Germany $4.257B 68.69
Nektar Therapeutics (NKTR) United States $4.164B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.040B 74.98
FibroGen (FGEN) United States $3.954B 116.21
Sage Therapeutics (SAGE) United States $3.647B 0.00
PTC Therapeutics (PTCT) United States $3.535B 0.00
ChemoCentryx (CCXI) United States $2.879B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.791B 11.29
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.276B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.087B 57.49
Xencor (XNCR) United States $2.048B 62.26
Tilray (TLRY) Canada $1.934B 0.00
Heron Therapeutics (HRTX) United States $1.896B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.883B 23.10
Corcept Therapeutics (CORT) United States $1.561B 17.51
USANA Health Sciences (USNA) United States $1.547B 16.17
Theravance Biopharma (TBPH) Cayman Islands $1.470B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Endo (ENDP) Ireland $1.386B 2.55
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.382B 9.43
Zogenix (ZGNX) United States $1.368B 0.00
Akebia Therapeutics (AKBA) United States $1.218B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.062B 32.91
Portola Pharmaceuticals (PTLA) United States $1.048B 0.00
Karyopharm Therapeutics (KPTI) United States $1.030B 0.00
Dermira (DERM) United States $1.022B 0.00
Radius Health (RDUS) United States $0.922B 0.00
Aerie Pharmaceuticals (AERI) United States $0.921B 0.00
ImmunoGen (IMGN) United States $0.835B 0.00
Collegium Pharmaceutical (COLL) United States $0.792B 0.00
Flexion Therapeutics (FLXN) United States $0.631B 0.00
Molecular Templates (MTEM) United States $0.610B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.586B 0.00
TherapeuticsMD (TXMD) United States $0.583B 0.00
Ardelyx (ARDX) United States $0.578B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.536B 65.00
Translate Bio (TBIO) United States $0.474B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.471B 20.32
Organogenesis Holdings (ORGO) United States $0.465B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.427B 0.00
Calithera Biosciences (CALA) United States $0.413B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.404B 0.00
Siga Technologies (SIGA) United States $0.403B 9.20
DURECT (DRRX) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
Recro Pharma (REPH) United States $0.382B 0.00
Lannett Co Inc (LCI) United States $0.377B 6.07
Harpoon Therapeutics (HARP) United States $0.372B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.367B 0.00
Indivior (INVVY) United States $0.355B 2.11
Spectrum Pharmaceuticals (SPPI) United States $0.346B 0.00
Concert Pharmaceuticals (CNCE) United States $0.329B 0.00
OptiNose (OPTN) United States $0.328B 0.00
Rafael Holdings (RFL) United States $0.326B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.299B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.267B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.260B 0.00
Ocular Therapeutix (OCUL) United States $0.258B 0.00
MEI Pharma (MEIP) United States $0.253B 0.00
KalVista Pharmaceuticals (KALV) United States $0.252B 0.00
IMV INC (IMV) Canada $0.242B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.224B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.201B 34.70
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
Jounce Therapeutics (JNCE) United States $0.189B 2.53
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.128B 0.00
Xeris Pharmaceuticals (XERS) United States $0.125B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Redhill Biopharma (RDHL) Israel $0.111B 0.00
Aquestive Therapeutics (AQST) United States $0.110B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.108B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Onconova Therapeutics (ONTX) United States $0.076B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.45
SCYNEXIS (SCYX) United States $0.064B 0.00
IsoRay (ISR) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Nivalis Therapeutics (ALPN) United States $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 22.81
Bellicum Pharmaceuticals (BLCM) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
PolarityTE (PTE) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Vical (BBI) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
India Globalization Capital (IGC) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cardiome Pharma (CORV) Canada $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Novan (NOVN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00